Thermogenic effects of sibutramine and its metabolites
Open accessThe DOI matches its Crossref record.
Abstract
The thermogenic activity of the serotonin and noradrenaline reuptake inhibitor sibutramine (BTS 54524; Reductil) was investigated by measuring oxygen consumption (VO 2) in rats treated with sibutramine or its two pharmacologically‐active metabolites. Sibutramine caused a dose‐dependent rise in VO 2, with a dose of 10 mg kg−1 of sibutramine or its metabolites producing increases of up to 30% that were sustained for at least 6 h, and accompanied by significant increases (0.5–1.0°C) in body temperature. Based on the accumulation in vivo of radiolabelled 2‐deoxy‐[3 H]‐glucose, sibutramine had little or no effect on glucose utilization in most tissues, but caused an 18 fold increase in brown adipose tissue (BAT). Combined high, non‐selective doses (20 mg kg−1) of the β‐adrenoceptor antagonists, atenolol and ICI 118551, inhibited completely the VO 2 response to sibutramine, but the response was unaffected by low, β 1‐adrenoceptor‐selective (atenolol) or β 2‐adrenoceptor‐selective (ICI 118551) doses (1 mg kg−1). The ganglionic blocking agent, chlorisondamine (15 mg kg−1), inhibited completely the VO 2 response to the metabolites of sibutramine, but had no effect on the thermogenic response to the β 3‐adrenoceptor‐selective agonist BRL 35135. Similar thermogenic responses were produced by simultaneous injection of nisoxetine and fluoxetine at doses (30 mg kg−1) that had no effect on VO 2 when injected individually. It is concluded that stimulation of thermogenesis by sibutramine requires central reuptake inhibition of both serotonin and noradrenaline, resulting in increased efferent sympathetic activation of BAT thermogenesis via β 3‐adrenoceptor, and that this contributes to the compound's activity as an anti‐obesity agent. British Journal of Pharmacology (1999) 126, 1487–1495; doi:10.1038/sj.bjp.0702446
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
Liu, Y. L., Connoley, I. P., Wilson, C. A., & Stock, M. J. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802847 · Cited by 313
Self-citationMitochondrial uncoupling as a target for drug development for the treatment of obesity.
Harper, J. A., Dickinson, K., & Brand, M. D. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00043.x · Cited by 250
Current and investigational antiobesity agents and obesity therapeutic treatment targets
Bays, H. E. (2004) · Obesity Research · doi:10.1038/oby.2004.151 · Cited by 228
Central Nervous System Biogenic Amine Targets for Control of Appetite and Energy Expenditure
Nelson, D. L., & Gehlert, D. R. (2006) · Endocrine · doi:10.1385/endo:29:1:49 · Cited by 78
Metadata
- Authors
- Connoley, I. P., Liu, Y., Frost, I., Reckless, I. P., Heal, D. J., & Stock, M. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-03
- Volume
- 126
- Issue
- 6
- Pages
- 1487-1495
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2073562658
- Cited by
- 141
- References
- 0
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thermogenic effects of sibutramine and its metabolites. https://app.cochat.ai/papers/10.1038/sj.bjp.0702446
- The paper
- Connoley, I. P., Liu, Y., Frost, I., Reckless, I. P., Heal, D. J., & Stock, M. J. (1999). Thermogenic effects of sibutramine and its metabolites. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0702446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.